摘要
硫化氢(H2S)作为一种毒性物质,在过去几十年中被公认为一种重要的内源性气体递质,在心血管系统的稳态中发挥着关键作用。近年来,越来越多的证据表明H2S对心肌缺血/再灌注(I/R)具有保护作用,引起了人们对H2S心脏保护作用的可能作用机制的越来越多的兴趣,并发现了多个靶点的参与。目前,通过体内外I/R损伤模型,如抗炎或抗氧化损伤模型,以及Ssuf水化修饰蛋白质如离子通道的机制,已经提出并验证了许多机制。特别关注的是线粒体的保存和抗凋亡机制,最后甚至描述了促进血管生成的作用。同时,能够释放H2S(单独作为H2S供体)或与杂化分子中的另一种药物结合的分子的设计、开发和药理特性,导致了在心脏保护药物的全景中产生新的化学实体。
关键词: 硫化氢,缺血再灌注,心脏保护,H2S供体,气体递质,心肌损伤。
Current Medicinal Chemistry
Title:The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury
Volume: 25 Issue: 34
关键词: 硫化氢,缺血再灌注,心脏保护,H2S供体,气体递质,心肌损伤。
摘要: Hydrogen sulfide (H2S), previously known only as a toxic agent, in the last decades has been recognized as an important endogenous gasotransmitter, playing a key role in the homeostasis of the cardiovascular system. In the last years, the growing evidence about a protective role exhibited by H2S against myocardial ischemia/reperfusion (I/R), led to an increasing interest for the possible mechanism of action accounting for the H2S cardioprotective effect, and to the discovery of the involvement of several targets. Currently, many mechanisms of action have been proposed and verified through in vitro and in vivo models of I/R injury, such as the anti-inflammatory or the anti-oxidant ones, or mechanisms of Ssufhydration able to modify proteins such as ion channels. Particular attention was focused on the mitochondrial preservation and on anti-apoptotic mechanisms, and finally even a pro-angiogenesis effect has been described. At the same time, the design, the development and the pharmacological characterization of moieties able to release H2S, employed alone as H2S-donor, or conjugated with another drug in hybrid molecules, led to the production of novel chemical entities in the panorama of cardioprotective drugs.
Export Options
About this article
Cite this article as:
The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury, Current Medicinal Chemistry 2018; 25 (34) . https://dx.doi.org/10.2174/0929867325666180212120504
DOI https://dx.doi.org/10.2174/0929867325666180212120504 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene Therapy Targeting Inflammation in Atherosclerosis
Current Pharmaceutical Design Cell Therapy for Inner Ear Diseases
Current Pharmaceutical Design Microbial Transformation of Triterpenoids
Mini-Reviews in Organic Chemistry Application of Glutathione as Anti-Oxidative and Anti-Aging Drugs
Current Drug Metabolism Novel Genetic and Peptide-Based Strategies Targeting the Bcl-2 Family, an Update
Recent Patents on DNA & Gene Sequences Editorial (Hot Topic: Novel Biomarkers in the Prognosis, Progression and Treatment of Cardiovascular Disease: The Role of microRNAs )
Current Topics in Medicinal Chemistry Blood Pressure Reduction in the Primary and Secondary Prevention of Stroke
Current Vascular Pharmacology New Frontiers in the Management of Acute Coronary Syndromes: Cangrelor and Elinogrel
Recent Patents on Cardiovascular Drug Discovery Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
Current Pharmaceutical Design Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris
Current Drug Safety Peptides Targeting Gap Junctional Structures
Current Pharmaceutical Design Smoking and Cardiovascular System: Cellular Features of the Damage
Current Pharmaceutical Design Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease
Current Medicinal Chemistry To Be-et, or Not to Be-et, That is the Question: The Role(s) of Nitrate and Nitrite in Health and Illness
Reviews on Recent Clinical Trials Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology Endothelin and the Ischaemic Heart
Current Vascular Pharmacology